SNAP-8 Spray

Research Benefits

• Neuromuscular Junction Research — SNAP-8 (Acetyl Octapeptide-3) modulates SNARE complex assembly, providing a topical research tool for studying neuromuscular signal transduction.
• Anti-Wrinkle Mechanism Studies — By competing with SNAP-25 for SNARE complex formation, SNAP-8 reduces vesicle fusion and neurotransmitter release at the dermal neuromuscular junction.
• Cosmeceutical Research — SNAP-8 is extensively studied as a topical peptide for reducing expression lines, with published studies demonstrating measurable effects on skin surface topology.
• Non-Invasive Alternative — As a topically applied peptide, SNAP-8 provides a non-invasive model for studying SNARE-mediated exocytosis modulation.

Mechanism of Action

SNAP-8 (Acetyl Octapeptide-3) is a synthetic peptide that mimics the N-terminal domain of SNAP-25, a key component of the SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment protein REceptor) complex.

SNARE Complex Competition: SNAP-8 competes with native SNAP-25 for binding positions in the SNARE complex, which consists of SNAP-25, syntaxin-1, and VAMP-2 (synaptobrevin). By partially displacing SNAP-25, it destabilizes the complex and reduces vesicle-membrane fusion efficiency.

Reduced Exocytosis: Destabilized SNARE complexes result in diminished acetylcholine release at neuromuscular junctions in the skin, reducing muscle contraction intensity and associated expression lines.

Topical Penetration: The acetylated N-terminus enhances lipophilicity, improving stratum corneum penetration. The eight-amino-acid sequence is small enough for transdermal delivery to the dermal-epidermal junction.

Comparison to Botulinum Toxin: While botulinum toxin cleaves SNARE proteins irreversibly, SNAP-8 acts as a competitive inhibitor with reversible, dose-dependent effects on vesicle fusion.

Research Protocol

Derived from published research. For research use only.

Preparation

SNAP-8 is typically dissolved in aqueous formulations at 3-10% w/v for topical application studies. It is water-soluble and does not require organic solvents.

Research Applications (from published studies)

• Topical studies: 3-10% SNAP-8 in cream or serum base, applied twice daily for 28-56 days with silicone replica or profilometry assessment.
• In vitro neuromuscular: 50-500 μM in primary neuron/myocyte co-cultures, measuring ACh release via patch-clamp or calcium imaging.
• Skin penetration: Franz diffusion cell with dermatomed skin, 5% SNAP-8 donor solution.

Storage

Store lyophilized at -20°C. Solutions at 2-8°C are stable for 30+ days.

Safety & Handling

Research Use Only.

Storage Conditions

• Lyophilized: -20°C
• Aqueous solutions: 2-8°C, stable for 30+ days
• Compatible with most cosmetic formulation excipients

Known Considerations from Literature

• SNAP-8 is designed for topical application. Systemic administration is not typical in published research.
• No significant skin irritation or sensitization has been reported in published dermal tolerance studies.
• Effects are reversible and dose-dependent, unlike irreversible botulinum toxin cleavage.

Handling

Standard PPE. No special ventilation required for aqueous solutions.

Frequently Asked Questions

What is SNAP-8?

SNAP-8 (Acetyl Octapeptide-3) is a synthetic peptide that mimics part of the SNAP-25 protein to competitively modulate SNARE complex assembly, reducing neurotransmitter-mediated muscle contraction at the skin level.

How does SNAP-8 differ from botulinum toxin in research?

Botulinum toxin irreversibly cleaves SNARE proteins (specifically SNAP-25 or VAMP-2 depending on serotype). SNAP-8 is a competitive inhibitor with reversible effects, does not require injection, and has no paralytic activity.

Is SNAP-8 water-soluble?

Yes. SNAP-8 is fully water-soluble and compatible with aqueous formulations, making it suitable for topical research preparations without organic solvents.

What purity is this product?

BeaCapra SNAP-8 is ≥99% pure by HPLC with COA documentation.